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Abstract 
There is limited high-quality evidence supporting psychological treatments for functional 
neurological disorders (FND), and what evidence exists suggests that the impact of such 
treatments could be improved. One way to increase effectiveness is to utilise approaches that 
can have impact across heterogeneous FND presentations. Acceptance and Commitment 
Therapy (ACT) targets a trans-diagnostic process called psychological flexibility, and is used 
effectively to integrate multidisciplinary treatments in other clinical contexts. Here, we 
present a consecutive case series (N = 8) of a relatively brief (6 to 10 sessions) ACT 
intervention, delivered face-to-face by a clinical psychologist in an outpatient 
neuropsychology service. Treatment aimed to reduce symptom interference and improve 
mood via improvements in psychological flexibility. Service users presented with a range of 
FND symptoms (e.g. syncope, limb paralysis, paresthesia). Following treatment, five 
participants showed reliable improvements in symptom interference (WSAS), two to the 
extent of clinical significance; four had reliable improvements in mood (CORE-10), two 
within the range of clinical significance. There were no reliable deteriorations in symptom 
interference or mood. Marked variation was apparent on the measure of psychological 
flexibility (AAQ-II), with four reliable improvements, three within the range of clinical 
significance, but also two reliable deteriorations. These promising results suggest that further 
investigation of an ACT approach to FND is warranted. Future studies should include 
measures of psychological flexibility with greater comprehensibility.  
 
Keywords: acceptance and commitment therapy; mindfulness; functional neurological 
disorders; functional movement disorders; conversion disorders.  
 
 
 
 
 
 
 
 
 
 
ACT for FND 
3 
 
Key Practitioner Message 
x Acceptance and commitment therapy (ACT) is a trans-diagnostic treatment. This may 
enable impact across the psychologically heterogeneous FND population.  
x This case series provides a promising evaluation of a brief ACT intervention, with 
the majority experiencing large improvements in symptom interference and/or mood.  
x A multi-disciplinary ACT approach (i.e. also including physiotherapists, occupational 
therapists) may be required to affect improvements in those with the most severe 
symptom interference. 
x This treatment approach did not have a priori assumptions regarding the cause of 
FND, and consequently placed emphasis on participant experiences of living with 
FND.  
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A case series of Acceptance and Commitment Therapy (ACT) for reducing 
symptom interference in functional neurological disorders 
 
Introduction 
Functional Neurological Disorders (FND), sometimes called µconversion disorders¶, involve 
neurological symptoms, such as seizures, limb weakness, and dystonia that are inconsistent 
with known disease pathologies but are not thought to be feigned (van der Hoeven et al., 
2015). They detrimentally affect functioning, quality of life and mood (Carson et al., 2011; 
Vroegop, Dijkgraaf, & Vermeulen, 2013), and although some people become symptom free 
following diagnosis, for others symptoms persist and proliferate (Duncan et al., 2014; 
Gelauff, Stone, Edwards, & Carson, 2014; McKenzie, Oto, Graham, & Duncan, 2011).  
It is unclear what interaction of biopsychosocial factors accounts for FND in any given case. 
However, many theorise that emotional processes have primacy; suggesting that, for 
example, FND result from the suppression into the subconscious of traumatic experiences 
(Breuer, 1955), and/or emotion dysregulation (Vuilleumier, 2005). The high incidence of 
trauma, alexithymia (Demartini, Petrochilos, et al., 2014), psychiatric diagnoses (Bowman, 
1993; Stone, Warlow, & Sharpe, 2010) and evidence of differential emotional responding in 
FND (Blakemore, Sinanaj, Galli, Aybek, & Vuilleumier, 2016), support such theories. 
However, there is heterogeneity in presentation: some with FND do not report antecedent 
trauma, emotion dysregulation, or have pre-morbid psychiatric diagnosis (Stone & Edwards, 
2011; van der Hoeven et al., 2015). Indeed, newer theories posit several routes to the 
development or maintenance of these conditions, eventually also involving attentional 
dysfunction, and altered sensory feedback from movement (Edwards, Adams, Brown, Pareés, 
& Friston, 2012).  
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In clinical practice, people with FND are often referred for psychological therapy, medication 
for mood or physiotherapy. Reviews of psychological interventions have uncovered little 
supportive high-quality evidence (Martlew, Pulman, & Marson, 2014; Ricciardi & Edwards, 
2014); however, there is an emerging evidence-base. Small-scale or uncontrolled trials of 
psychodynamic approaches have yielded promising (Mayor, Howlett, Grunewald, & Reuber, 
2010) or mixed (Kompoliti, Wilson, Stebbins, Bernard, & Hinson, 2014) results. Trials of 
traditional cognitive behaviour therapy (CBT) with very small sample sizes have returned 
positive evaluations of (Dallocchio, Tinazzi, Bombieri, Arnó, & Erro, 2016; LaFrance et al., 
2014). Regarding larger trials, a randomised control trial (RCT) of a CBT guided self-help 
intervention observed a short-term effect on symptom severity, with a mixed impact on mood 
(Sharpe et al., 2011), while a pilot RCT of higher-intensity CBT returned similar results 
(Goldstein et al., 2010). Thus, while promising, it seems that the impact of psychological 
treatments for FND could be improved.  
Acceptance and Commitment Therapy (ACT) for FND  
Although ACT overlaps with CBT (e.g. centrality of behaviour change) and psychodynamic 
treatments (e.g. relational), it emerges from differing philosophical assumptions, and 
consequently has some novel features (for discussion see Herbert & Forman, 2013). Most 
saliently, treatment is not necessarily focused on the control of unwanted emotions or on 
aligning beliefs with essential truths. Instead ACT aims to engender a process called 
SV\FKRORJLFDOIOH[LELOLW\GHILQHGDVFRQVLVWLQJRIWKUHHFRPSRQHQWV³«the capacity to 
persist or to change behaviour in a way that includes conscious and open contact with 
thoughts and feelings (openness), 2) appreciates what the situation affords (awareness), and 
VHUYHVRQH¶VJRDOVDQGYDOXHVHQJDJHPHQW´(McCracken & Morley, 2014, p. 225.) ACT 
uses a range of methods to improve psychological flexibility: mindfulness and perspective-
taking exercises are used to create the conditions for participants to choose actions that are 
ACT for FND 
6 
 
consistent with their values, for example. There is strong evidence supporting ACT for 
improving outcomes in chronic pain (Hann & McCracken, 2014), and growing evidence in 
mental health conditions (A-Tjak et al., 2015) and chronic diseases (Graham, Gouick, Krahé, 
& Gillanders, 2016). 
For a range of different reasons, several have advanced that ACT may be particularly useful 
in the context of FND (G. Baslet, Dworetzky, Perez, & Oser, 2015; Gaston Baslet & Hill, 
&RSH3RROH	$JUDZDO*UDKDP6WXDUW2¶+DUD	.HPS. First, 
because ACT¶V target, psychological flexibility, is a trans-diagnostic process (Levin et al., 
2014) it may have impact across the psychological heterogeneity evident in FND (Graham et 
al., 2017). Ergo, where FND is experienced as the result of emotion dysregulation or 
underlying mental health conditions, then ACT, like many other psychological therapies, is 
potentially applicable (Gaston Baslet & Hill, 2011; Cope et al., 2017). However, as treatment 
is not predicated on uncovering a psychological cause/maintaining factor for symptoms, ACT 
may be equally applicable to those not readily reached by existing approaches. For instance, 
where there is no control over symptoms and an absence of emotional antecedents/modifiers, 
then distress and illness beliefs may occur simply as a reflection of the context. Here $&7¶V
focus on enhancing personally meaningful activity via openness and awareness offers scope 
for improvements in functioning and quality of life ± and even with residual symptoms 
(Graham et al., 2016; Graham et al., 2017). Second, there are calls for multidisciplinary 
treatments for FND (Demartini, Batla, et al., 2014; Stone & Carson, 2017) and, as has been 
consistently demonstrated in chronic pain contexts (e.g. Vowles & McCracken, 2008), ACT 
offers an effective framework for integrating multidisciplinary approaches.  
Thus, over a 12-month period in routine clinical practice offered ACT to a proportion of our 
outpatient service users with FND. Symptom interference (primary outcome), mood and 
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psychological flexibility (secondary outcomes) were measured before and after treatment and 
analysed via calculation of reliable and clinically significant change. 
Methods 
Design 
A case series, involving outcome data collected at pre- and post- intervention within routine 
clinical practice (ethics review: National Health Service [NHS] audit/service evaluation).  
Participants  
All included participants had a diagnosis of FND, which was first delivered by a neurologist. 
They were then routinely referred to an outpatient NHS clinical neuropsychology service, 
which provides treatment that is free of charge at the point of access. An initial meeting 
between a clinician and those referred to the service assessed suitability for a short-term 
psychological intervention. Participants offered this ACT intervention were those who (a) 
were judged as likely to benefit from a short-term outpatient psychological treatment that 
went beyond simple psychoeducation, and (b) consented to participate in psychological 
therapy, and (c) after explanation were interested in an ACT approach. To allow for adequate 
exposure to treatment, all service users who completed at least six sessions of ACT were 
included in the analysis.  
Procedure 
Service users were treated by a clinical psychologist with training in ACT. In line with 
service parameters, they were offered up to eight weekly-to-fortnightly, hour-long face-to-
face treatment sessions. This number could be extended slightly based on need. Outcomes 
were measured pre- and post- intervention using validated self-report questionnaires of 
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symptom interference (primary outcome), mood, and, psychological flexibility (secondary 
outcomes).  
Intervention 
A detailed case example of this intervention can be found here: Graham et al., (2017). The 
intervention comprised assessment, formulation and treatment stages. Within the assessment, 
the VHUYLFHXVHU¶V understanding of FND was elicited. The therapist discussed FND as 
something that is reasonably common, is produced by brain function, with some people 
recovering from symptoms over time. We assessed for the possibility that better 
psychological flexibility might reduce the symptom interference caused by FND. Assessment 
resulted in an individualised formulation, which was then followed by an individualised 
intervention. Formulation and intervention involved functional analysis: participants were 
encouraged to notice clinically relevant behaviours (e.g. attempts at symptom control, 
rumination etc.), then to become aware of their function, consequences and effectiveness ± in 
terms of making progress on their own values (Table 1). The clinical conversation (relational 
framing, metaphors; Villatte, Hayes, & Villatte, 2015) and experiential tasks were used as 
vehicles for psychological flexibility (see Table 1). In line with the apparent psychological 
heterogeneity in FND presentations, treatment could be directed towards functioning well in 
the presence of FND, and/or other sources of pain (difficult social contexts, emotions, 
memories etc.), given what was workable within the number of treatment sessions available.    
Measures  
Work and Social Adjustment Scale (WSAS) 
The WSAS (Mundt, Marks, Shear, & Greist, 2002) is a five-item measure of symptom 
interference ascribed to an identified condition (here FND). It has shown acceptable 
psychometric properties (Mundt et al., 2002). Each item represents an area of functioning 
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(e.g. socialising, working). Responses are made on a scale from 0 (not at all impaired) to 8 
(severely impaired). Scores range from 0 to 40, with higher scores indicating greater 
symptom interference. We made this the primary outcome because it captures improvements 
in functioning (which may occur even with symptoms unchanged) ± as opposed to narrow 
measurement of symptom severity alone.  
Clinical Outcomes in Routine Evaluation ± 10 (CORE-10)  
The CORE-10 is a ten-item measure of mood and distress (Barkham et al., 2013). Scores 
range from 0 to 40, with higher scores indicating greater mood disturbance. It has clinical 
cut-offs of >11 for general psychological distress and >13 for depression. Initial 
psychometric evaluations of the CORE-10 have shown strong psychometric properties, for 
use in psychological therapy contexts (Barkham et al., 2013). This was chosen a secondary 
outcome variable because mood disturbance is a frequent FND comorbidity (Stone, 2009).   
Acceptance and Action Questionnaire II (AAQ-II)  
The AAQ-II (Bond et al., 2011) was chosen because it is the most widely-used measure of 
Psychological flexibility. It has 7 items HJ³(PRWLRQVFDXVHSUREOHPVLQP\OLIH´, and 
participants respond to each on a scale, ranging from 1 (never true) to 7 (always true). Total 
scores can range from 7 to 49, with higher scores indicating worse psychological flexibility. 
Quantitative studies suggest that the AAQ-II has strong psychometric properties (Bond et al., 
2011). However, some have questioned the content validity and comprehensibility of the 
questionnaire (Francis, Dawson, & Golijani-Moghaddam, 2016; Wolgast, 2014).  
Analysis 
The Reliable Change Index (RCI) and Clinically Significant Change scores (CSC) were 
calculated from the pre- and post- intervention data gathered from each service user. These 
analyses use normative data (where possible) to calculate parameters indicating that, a) 
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change is greater than measurement error (reliable change), and b) change is to the extent that 
it indicates clinical recovery (clinically significant change; (Jacobson & Truax, 1991; Morley 
& Dowzer, 2014). RHSHDWHGPHDVXUHV&RKHQ¶Vd was calculated to investigate the magnitude 
of treatment effects. As recommended (Morris & DeShon, 2002), the calculation included 
pre-intervention standard deviation at both time-points. The convention for rating magnitude 
was: Large: d > 0.8; Medium: d = 0.5 ± 0.8; Small: d < 0.4. 
Results 
The eight service users presented with at least one of the following FND symptoms: arm 
tremor, leg weakness/paralysis, propriospinal myoclonus, paresthesia, visual disturbance, 
syncope. Most were female, and ages ranged from 18 to 65 years. Many reported co-morbid 
health or mental health conditions. As evident in Figure 1, pre-intervention functional 
impairment was generally quite high, the average being slightly higher than a functional 
movement disorder sample included in a previous trial of physiotherapy (M = 24.7, SD = 7.9; 
Nielsen et al., 2016). All service users scored above both cut-offs (psychological distress, 
probable depression) on the CORE-10 (Figure 2). As shown in Figure 3, the initial 
psychological flexibility of the group was similar a sample collected from an outpatient 
counselling service (M = 28.34, SD = 9.92; Bond et al., 2011). Service users attended 
between six and 10 treatment sessions (inclusive). 
On average, improvement in FND symptom interference was of a large magnitude (d = 1.02), 
with five (of eight) experiencing reliable improvements - two to the extent that it indicated 
clinical recovery (Figure 1). There were no reliable deteriorations in symptom interference. 
Similarly, a large improvement in mood was noted (d = 1.70); four service users showed 
reliable improvements, two to the extent of clinical recovery, with no reliable deteriorations 
(Figure 2). Improvement in psychological flexibility was of a medium magnitude (d =0.77), 
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with reliable improvement evident in four cases, two to the extent that it indicated clinical 
recovery. However, two reliable deteriorations - one to the extent of clinical deterioration - 
were evident (Figure 3).  Those four who experienced an improvement in psychological 
flexibility also experienced improvements in symptom interference and mood; while the two 
with a reliable decline in psychological flexibility reported no change in symptom 
interference or mood. There was no clear pattern of difference in the number of treatment 
sessions attended between those who did (6-10 sessions) and did not (8 -10 sessions) 
experience reliable improvements in the primary outcome.  
Discussion 
We offered ACT for FND due to its theoretical applicability across the psychological 
heterogeneity apparent within this group, and demonstrated effectiveness in similar contexts 
(A-Tjak et al., 2015; Hann & McCracken, 2014). This pragmatic case series provided a 
promising initial evaluation of this brief intervention. It was notable that most service users 
had reliable improvements in symptom interference and/or mood, with many to the extent of 
clinical significance. Indeed, these within group improvements were of a large magnitude, 
and there were no reliable deteriorations. Nonetheless, a key characteristic of the smaller 
group of non-responders on the primary outcome (n = 3), was that they reported extremely 
severe functional impairment at presentation /40 on the WSAS). This is consistent with 
other clinical reports showing that those with extremely severe symptoms are less likely to 
respond to a brief psychological intervention alone (Davison, Sharpe, Wade, & Bass, 1999). 
This group may have required a longer duration of treatment or an integrated 
multidisciplinary approach (i.e. involving physiotherapy, and other treatments.) We advance 
that, as is done effectively in chronic pain contexts (Vowles & McCracken, 2008), ACT 
might be used to integrate such multidisciplinary treatments for FND.  
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Marked variability of response was evident on our measure of psychological flexibility 
(AAQ-II), with large improvements and also two reliable deteriorations. Although 
deteriorations in psychological flexibility may have occurred, we suspect that the 
comprehensibility of the AAQ-II questionnaire best explains this phenomenon. The AAQ-II 
involves esoteric concepts - for H[DPSOH³0\SDLQIXOPHPRULHVSUHYHQWPHIURPKDYLQJD
IXOILOOLQJOLIH´6XFKFRQFHSWVmay be difficult to understand until one is socialised to the 
treatment model, potentially leading to a worsening of score as understanding improves, as 
well as vice versa. Future researchers might consider using psychological flexibility measures 
that appear to have greater comprehensibility - for example the CompACT questionnaire 
(Francis et al., 2016).  
Many psychological approaches to FND make assumptions that specific psychological 
factors cause or maintain symptoms (e.g. Russell et al., 2016; Dallocchio et al., 2016). 
Therapy then targets these psychological factors to directly ameliorate symptoms. 
Alternatively, ACT does not require a priori assumptions regarding FND aetiology, and 
focuses first on living well in a difficult context. This allows consideration to be given to a 
broad range of psychological factors and responses to living with FND. Consequently, 
closely gXLGHGE\HDFKSDUWLFLSDQW¶VH[SHULHQFHV of living with FND we aimed to help them 
enact behaviours that were in line with their own personal values. For instance, where the 
function of participant behaviour appeared to include uncovering an alternative cause for 
their symptoms, their attention was directed to the consequences of such behaviour. Cause-
finding behaviours could be helpful: noticing the possible influence of emotions on symptom 
experiences, or seeking further applicable treatments. These behaviours could also be 
unhelpful ± mirroring the stagnation of worry and rumination, increasing symptom-focused 
attention or leading to ineffective use of healthcare services.  
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This experiential and cause-agnostic stance may mean that services users who do not accept a 
psychological explanation for FND could fully partake in, and benefit from, ACT. 
Nonetheless, although we posit that ACT may have application across FND sub-groups, 
given the breadth of heterogeneity in FND other psychological treatments might be most 
suitable for certain presentations (Agrawal, Gaynor, Lomax, & Mula, 2014). Also, some with 
FND may not require or want psychological therapy. 
Methodological limitations 
Using pre- post- intervention data collected from clinic we calculated RCI and CSC scores. 
This analysis method allowed us to control for measurement error as an explanation for 
treatment effects. However, as we did not use an experimental design we could not exclude 
further threats to the validity of our findings (e.g. regression to mean, placebo etc.; Smith, 
2012). This, alongside several others factors (e.g. therapist-condition confound, lack of ACT 
fidelity measurement) means that further testing is required before ACT might be considered 
an unequivocally effective psychological approach to FND. Due to the pragmatic nature of 
this study we did not collect information to further characterise our cohort (e.g. 
demographics, proportion offered ACT, participant beliefs about the cause of FND etc.) Also, 
our sample may have been selective because participants had to progress through several 
assessment stages before they could partake in treatment. Finally, the exclusive reliance on 
standardised self-report questionnaires is a limitation. Although some might argue that 
clinician ratings of change in outcomes would have been a useful addition to the assessment 
battery, we suggest that the addition of behavioural data (e.g. idiographic measurement of the 
frequency of enactment of behaviours consistent with values) may be more informative, and 
this would also be consistent with the treatment model.  
Conclusion 
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This case series advances ACT as a promising psychological intervention for reducing 
symptom interference and improving mood in FND. Larger controlled studies are now 
required to further test the hypothesis that ACT is an efficacious treatment for this group, 
while more comprehensive measurement is required to investigate whether improvement 
occurs via psychological flexibility, as implied by the treatment model.  
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Table 1 
Some examples of ACT methods that were used, arranged by the targeted aspect of psychological 
flexibility (informed by a range of sources, mostly Harris, 2009; Hayes, Strosahl, & Wilson, 1999; 
Villatte et al., 2015; Wilson 7 DuFrene, 2009).  
Aspect of 
psychological 
flexibility 
Therapy Methods  
Engagement  
 
Consciously aligning 
RQH¶V behaviour with 
RQH¶V values  
 
 
 
 
 
Example functional analysis* 
Behaviour: Avoidance of an important social event. 
Antecedent: Invitation to a social situation, accompanied by fear and thoughts regarding others 
seeing self as ill or infirmed; Consequent: less anxiety, fewer thoughts of self as ill (also boredom 
and ODFNRISURJUHVVRQRQH¶VYDOXHV); Function: experiential avoidance of anxiety and thoughts 
regarding changed identity; Contingency: negatively reinforced via reduction in anxiety.  
 
Clinical conversation 
³:KHQ\RXIHHOPRVWDOLYHZKDWDUH\RXGRLQJRUQRWGRLQJ"´ 
 
³'LG\RXQRWLFHZKHWKHUWKDWZDVDVWHSWRZDUGVRUDZD\IURPZKDW¶VLPSRUWDQWWR\RX"´ 
 
³:KDWZRXOG\RXZDQW\RXUOLIHWRORRNOLNHfive years from now...with FND"´ 
 
Experiential Tasks 
- 90th birthday party: Asking participants to bring to mind their 90th birthday and to consider 
what they would want to be said about how they had lived their life. 
- Values and action discrepancy: writing down/exploring the importance of different values 
and how often participants are choosing behaviours that are consistent with these.  
- Smallest possible step: Identifying and consistently enacting the smallest possible steps 
DFWLYLWLHVWKDWFDQEHGRQHQRZWRJHWEDFNRQWUDFNZLWKRQH¶VYDOXHV 
Openness 
 
Conscious and open 
contact with thoughts 
and feelings (emotions 
and bodily sensations)  
 
 
 
 
 
Example functional analysis* 
Behaviour: Worry/rumination on cause of FND. 
Antecedent: Noticing a worsening of a symptom; Consequent: excessive attention towards 
symptoms (to the exclusion of other meaningful aspects of life); Function: Gain certainty/truth 
regarding cause/prognosis of symptoms; Contingency: Historically, problem-solving negatively 
reinforced in reducing discomfort (e.g. relationships, work etc) and positively reinforced via 
achievement (e.g. work, school, from parents.) 
 
Clinical conversation 
³«LWVRXQGVOLNHWKRVHSDLQIXOWKRXJKWVDQGIHHOLQJVDUHDURXQGDORWRIWKHWLPH- almost like living 
ZLWKDQDQQR\LQJIODWPDWH"´ 
 
³«DQGZKHQWKRVHSDLQIXOPHPRULHVFRPHWRPLQGZKDWKDSSHQVQH[W":KDWGR\RXGR when they 
DUHSUHVHQW"´ 
 
Experiential Tasks 
- Workability exercise: noticing where attempts to control, or ameliorate painful thoughts, 
feelings and sensations, are themselves interfering with values-consistent behaviour.  
- Practicing slowing down and attending to painful thoughts and feelings as they arise within 
the session, within the relationship with the therapist.   
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Awareness 
 
Appreciation of what the 
present situation affords 
 
 
 
 
 
 
 
Example functional analysis* 
Behaviour: Dissociation. 
Antecedent: encountering stimuli associated with stressful early experience; Consequent: less present 
in/less attentive to the present; Function: Learned protective behaviours, experiential avoidance of 
present unwanted memories and feelings; Contingency: negatively reinforced as method for 
avoiding re-experiencing difficult memories and feelings.  
 
Clinical conversation 
³,WVRXQGVOLNH\RXDUHVD\LQJWKDt your thoughts about yourself change quite often, almost like the 
weather«ZKDW¶VWKHZHDWKHUOLNHQRZ"´ 
 
³«GR\RX QRWLFHZKDWIHHOLQJVWKRXJKWVSRVVLELOLWLHVDUHKHUHULJKWQRZ«"´ 
 
³,IDQROGHU\RX± say you in your eighties ± walked into this room, what would KHVHH"´ 
 
Experiential Tasks 
- Notice who is noticing: a mindfulness task that involves noticing that one can observe 
thoughts and feelings.  
- Mindfulness of the present moment: practicing attending to a range of experiences in the 
present moment.  
- Perspective taking: using deictic framing to view a clinically significant event from 
differing perspectives (person, place, and time).  
 
*Note. Behaviours such as those described in these examples can have a number of different 
functions, dependent on person and context. Thus, these behaviours do not always have the 
functions described in these examples, and none of the described methods are implicitly or 
H[FOXVLYHO\µPDODGDSWLYH¶ 
 
 
 
 
 
 
ACT for FND 
20 
 
 
a WSAS requires the presence of a condition, thus normative data not applicable; consequently, based on the 
guidance of Morley & Dowzer (2014), Criterion A was used to indicate clinically significant change.  
Figure 1 
Graph illustrating changes in symptom interference (WSAS) across the period of the interventiona 
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b &URQEDFK¶V alpha, clinical and non-clinical norms from Connell & Barkham (2007Į FOLQLFDOQRUPV
M = 19.70, SD =  7.70; non-clinical norms: M = 4.70, SD =  4.80) 
cAlthough Criteria B suggested by Morley & Dowzer (2014), Criterion C used as it is a more conservative value 
for clinically significant change, and commensurate with cut-offs suggested by Connell & Barkham (2007) 
Figure 2 
Graph illustrating changes in mood (CORE-10) across the period of the interventionb,c 
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Criterion C 
d&URQEDFK¶V alpha, clinical and non-clinical norms from Bond et al., (2011; Į =  0.88; clinical norms: M = 
28.34, SD =  9.92; non-clinical norms:M = 18.53, SD =  7.52 ). 
eCommensurate with the advice of Morley & Dowzer (2014), Criterion C used to identify clinically significant 
change.  
Figure 3 
Graph illustrating changes in psychological flexibility (AAQ-II) across the period of the 
interventiond,e 
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